Trial Profile
Interventional, Randomised, Double-blind 4-way Crossover Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2014
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Anxiety disorders; Generalised anxiety disorder; Major depressive disorder
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Lundbeck A/S
- 08 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Apr 2014 New trial record